©The Author(s) 2015.
World J Gastroenterol. Dec 21, 2015; 21(47): 13294-13301
Published online Dec 21, 2015. doi: 10.3748/wjg.v21.i47.13294
Published online Dec 21, 2015. doi: 10.3748/wjg.v21.i47.13294
Table 1 Baseline characteristics (n = 109)
| Characteristic | n (%) |
| Male gender | 51 (46.8) |
| Body mass index (kg/m2), mean (SD) | 25.6 (4.9) |
| ASA score III-IV | 67 (61.5) |
| Tumor site | |
| Upper | 21 (19.3) |
| Middle | 43 (39.4) |
| Lower | 38 (34.9) |
| All levels | 7 (6.4) |
| UICC tumor stage | |
| I | 27 (24.8) |
| II | 31 (28.4) |
| III | 41 (37.6) |
| IV | 10 (9.2) |
| Tumor type | |
| Intestinal | 50 (45.9) |
| Diffuse | 56 (51.4) |
| Mixed | 3 (2.8) |
| Lymph node invasion | |
| No | 45 (41.2) |
| Yes | 64 (58.7) |
| Type of surgery | |
| Total gastrectomy | 103 (94.5) |
| Subtotal gastric resection | 6 (5.5) |
| D2-lymph node dissection | 109 (100) |
| Splenectomy | 48 (44.0) |
| Cholecystectomy | 19 (17.4) |
| Additional organ resection due to cancer invasion | 10 (9.2) |
| Radicality | |
| R0 | 104 (95.4) |
| Neoadjuvant/adjuvant treatment | |
| No | 69 (63.3) |
| Neoadjuvant chemoradiotherapy | 2 (1.8) |
| Adjuvant chemotherapy | 26 (23.9) |
| Adjuvant chemoradiotherapy | 12 (11.0) |
- Citation: Mrena J, Mattila A, Böhm J, Jantunen I, Kellokumpu I. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer. World J Gastroenterol 2015; 21(47): 13294-13301
- URL: https://www.wjgnet.com/1007-9327/full/v21/i47/13294.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i47.13294